<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03511612</url>
  </required_header>
  <id_info>
    <org_study_id>87RC17_0075 (ABIOSCILLO)</org_study_id>
    <nct_id>NCT03511612</nct_id>
  </id_info>
  <brief_title>Comparison of the Ankle-Brachial Index Measurement Using a Specific Oscillometric Device vs. the Doppler Method</brief_title>
  <acronym>ABIOSCILLO</acronym>
  <official_title>Comparison of the Ankle-Brachial Index Measurement Using a Specific Oscillometric Device vs. the Doppler Method</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Limoges</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Limoges</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Several methods are available to measure ankle brachial index (ABI) non-invasively. A recent&#xD;
      scientific statement of the AHA considers the Doppler method as the reference. However&#xD;
      because Doppler devices are not widely available in primary care, several attempts have been&#xD;
      made to propose alternative methods, among whom oscillometric methods (automatic blood&#xD;
      pressure machines) have attracted most attention.&#xD;
&#xD;
      We hypothesize that:&#xD;
&#xD;
      - the diagnostic characteristics (i.e. sensitivity, specificity and AUC) of the oscillometric&#xD;
      method would be very good as compared to the Doppler method.&#xD;
&#xD;
      the oscillometric method would have better intra- and inter-observer reproducibilities as&#xD;
      compared to the Doppler method.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 24, 2018</start_date>
  <completion_date type="Actual">October 24, 2018</completion_date>
  <primary_completion_date type="Actual">October 24, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Measurement of the ABI</measure>
    <time_frame>Day of the inclusion</time_frame>
    <description>Measurement of the ABI, with Doppler method as reference</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">51</enrollment>
  <condition>Peripheral Arterial Disease, Ankle Brachial Index, Doppler</condition>
  <arm_group>
    <arm_group_label>Pattern A</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Intervention : Each subject has 3 measurements of ABI starting with oscillometric device and then using the Doppler method.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pattern B</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Intervention : Each subject has 3 measurements of ABI starting with Doppler method and then using oscillometric device.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Measure ankle brachial index (ABI)</intervention_name>
    <description>This is a head-to-head comparison of 2 methods of determination of the ABI, taking the Doppler method as the standard and the oscillometric device AVP as the challenger</description>
    <arm_group_label>Pattern A</arm_group_label>
    <arm_group_label>Pattern B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Patients referred with the suspicion of PAD, either because of:&#xD;
&#xD;
          -  symptoms in favor of intermittent claudication or more atypical pain when walking, or&#xD;
&#xD;
          -  asymptomatic individuals with the presence of at least 2 cardiovascular risk factors&#xD;
             among the following :&#xD;
&#xD;
               -  Men &gt; 60 years or women &gt; 65 years&#xD;
&#xD;
               -  Regular cigarette smoking &gt;10 years, either current or in the past&#xD;
&#xD;
               -  Treated Type-2 diabetes &gt;5 years or Type-1 diabetes &gt;20 years&#xD;
&#xD;
               -  Treated hypertension&#xD;
&#xD;
               -  High blood cholesterol (either total-C &gt;240 mg/dl or LDL-C &gt;160 mg/dl) or treated&#xD;
                  by statins or other lipid-lowering agents&#xD;
&#xD;
               -  Documented history of coronary artery disease (history of PCI or CABG, or&#xD;
                  previous myocardial infarction, or CAD documented by coronary angiography)&#xD;
&#xD;
               -  Documented history of ischemic stroke&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with revascularized PAD&#xD;
&#xD;
          -  Patients with critical limb ischemia or leg/foot ulcers&#xD;
&#xD;
          -  Cardiac arrhythmia: Atrial fibrillation, atrial flutter, frequent supra- and&#xD;
             ventricular ectopic beats&#xD;
&#xD;
          -  Patients under dialysis&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University Hospital</name>
      <address>
        <city>Limoges</city>
        <zip>87200</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <study_first_submitted>April 18, 2018</study_first_submitted>
  <study_first_submitted_qc>April 18, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 30, 2018</study_first_posted>
  <last_update_submitted>January 21, 2019</last_update_submitted>
  <last_update_submitted_qc>January 21, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">January 23, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Peripheral Arterial Disease</mesh_term>
    <mesh_term>Peripheral Vascular Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

